Clinical Trial Update: A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function [Phase 1]

View source ↗

Summary

Phase 1 study update of BGM0504 in healthy participants and participants with impaired renal function, including individuals with Type 2 Diabetes Mellitus and o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• BGM0504

Snippet

Sponsor: BrightGene Bio-Medical Technology Co., Ltd. | Conditions: Type 2 Diabetes Mellitus (T2DM), Overweight or Obese | Phase 1 | Status: COMPLETED